(Q37889382)

English

Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy

scientific article published on July 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

0 references

1 reference

based on heuristic

inferred from title

Cornelia Lass-Florl

16

object named as

Cornelia Lass-Flörl

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Werner J. Heinz

0 references

Oliver A Cornely

3

object named as

Oliver A Cornely

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Dieter Buchheidt

4

object named as

Dieter Buchheidt

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1

object named as

Markus Ruhnke

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Meinolf Karthaus

9

object named as

Meinolf Karthaus

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

author name string

Volker Rickerts

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Andreas Glöckner

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Werner Heinz

6

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Rainer Höhl

7

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Regine Horré

8

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Peter Kujath

10

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Birgit Willinger

11

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Elisabeth Presterl

12

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Peter Rath

13

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Jörg Ritter

14

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Axel Glasmacher

15

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Andreas H Groll

17

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

German Speaking Mycological Society

18

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Paul-Ehrlich-Society for Chemotherapy

19

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

279-310

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Oropharyngeal candidiasis in patients with HIV: suggested guidelines for therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Antimicrobials as a contributory factor in oral candidosis--a brief overview.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

The emergence of fungi as major hospital pathogens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Revisiting the Source of Candidemia: Skin or Gut?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Postmortem candidaemia: marker of disseminated disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candidosis and aspergillosis as autopsy findings from 1994 to 2003.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Risk factors for disseminated candidiasis in children with candidemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Role of Candida albicans in Granulomatous Tissue Reactions. I. In Vitro Degradation of C. albicans and Immunospecificity of Split Products

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Hepatic candidiasis in cancer patients: the evolving picture of the syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Attributable mortality of nosocomial candidemia, revisited

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

HIV-related oral manifestations among adolescents in a multicenter cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Esophageal candidiasis in human immunodeficiency virus-infected pediatric patients after the introduction of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Epidemiology of invasive candidiasis: a persistent public health problem

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

The epidemiology of candidemia in two United States cities: results of a population-based active surveillance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Sepsis in European intensive care units: results of the SOAP study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candida infections in children treated with conventional chemotherapy for solid tumors (transplant recipients excluded): The Institut Gustave Roussy Pediatrics Department experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candidemia in Finland, 1995-1999.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candidemia in Norway (1991 to 2003): results from a nationwide study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Management and outcome of bloodstream infections due to Candida species in England and Wales

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Invasive yeast infections other than Candida spp. in acute leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Mixed fungemia: incidence, risk factors, and mortality in a general hospital

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Uncommon opportunistic fungi: new nosocomial threats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Oral candidiasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

HIV-related oral disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Prevalence and classification of HIV-associated oral lesions.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Guideline vulvovaginal candidosis: Guideline of the German Dermatological Society, the German Speaking Mycological Society and the Working Group for Infections and Infectimmunology of the German Society for Gynecology and Obstetrics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Inflammatory response and clinical course of adult patients with nosocomial bloodstream infections caused by Candida spp.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Deeply invasive candidiasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candida colonization and subsequent infections in critically ill surgical patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Timing of treatment for nonneutropenic patients colonized with Candida

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Management of Candida species infections in critically ill patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Diagnosis of invasive fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Detection of bloodstream infections in adults: how many blood cultures are needed?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Detection of fifteen species of Candida in an automated blood culture system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for candida growth detection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Use of the BACTEC 9240 System with Mycosis-IC/F blood culture bottles for detection of fungemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Management of central venous catheters in patients with cancer and candidemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candidaemia in a large teaching hospital: a clinical audit

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Time to blood culture positivity as a marker for catheter-related candidemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Effect of antifungal therapy timing on mortality in cancer patients with candidemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (A

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Antifungal resistance in pathogenic fungi

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Has antifungal susceptibility testing come of age?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

EUCAST Technical Note on voriconazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

EUCAST technical note on fluconazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Antifungal susceptibility testing: practical aspects and current challenges

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

The utility of serology in diagnosing candidosis in non-neutropenic critically ill patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Use of DNA microarray technology and gene expression profiles to investigate the pathogenesis, cell biology, antifungal susceptibility and diagnosis of Candida albicans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Use of quantitative real-time PCR to study the kinetics of extracellular DNA released from Candida albicans, with implications for diagnosis of invasive Candidiasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Molecular detection and identification of Candida and Aspergillus spp. from clinical samples using real-time PCR.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Identification of human pathogens isolated from blood using microarray hybridisation and signal pattern recognition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Multiplex PCR identification of eight clinically relevant Candida species

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Improving molecular detection of Candida DNA in whole blood: comparison of seven fungal DNA extraction protocols using real-time PCR.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

An update on the molecular diagnosis of invasive fungal disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

New diagnostic tools for neonatal sepsis: the role of a real-time polymerase chain reaction for the early detection and identification of bacterial and fungal species in blood samples.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Molecular probes for the detection of pathogenic fungi in the presence of human tissue.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Hepatosplenic candidiasis: wheels within wheels.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Unusual enhancement pattern of liver lesions in hepatosplenic candidiasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A controlled trial of the tolerance of amphotericin B infused in dextrose or in Intralipid in patients with haematological malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Flucytosine--what is its future?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Flucytosine therapeutic monitoring: 15 years experience from the UK

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Newer systemic antifungal agents : pharmacokinetics, safety and efficacy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Clinical pharmacology of antifungal compounds

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Anidulafungin versus fluconazole for invasive candidiasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Development of candidemia on caspofungin therapy: a case report.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Voriconazole: review of a broad spectrum triazole antifungal agent

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Correlates of acute renal failure in patients receiving parenteral amphotericin B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Mortality and costs of acute renal failure associated with amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Amphotericin B: time for a new "gold standard".

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Treatment-related risk factors for hospital mortality in Candida bloodstream infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Treatment of Candida infections with amphotericin B lipid complex

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candida endocarditis: contemporary cases from the International Collaboration of Infectious Endocarditis Merged Database (ICE-mD).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Infective endocarditis in intravenous drug abusers and HIV-1 infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Systemic candidiasis in Spanish heroin addicts: a possible source of infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Early Removal of Central Venous Catheter in Patients with Candidemia Does Not Improve Outcome: Analysis of 842 Patients from 2 Randomized Clinical Trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Intravascular catheter-related infections: advances in diagnosis, prevention, and management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Central venous catheter-related infections in hematology and oncology : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Antifungal combinations against Candida albicans biofilms in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Diagnosis and management of fungal infections and pneumocystis pneumonitis in pediatric cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Clinical pharmacology of antifungal agents in pediatric patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Amphotericin B lipid complex in pediatric patients with invasive fungal infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Lack of evidence of amphotericin B toxicity in very low birth weight infants treated for systemic candidiasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Liposomal amphotericin B (AmBisome) in the treatment of neonatal candidiasis in very low birth weight infants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Population pharmacokinetics of amphotericin B lipid complex in neonates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Combination therapy for systemic mycosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Fungal infections of the CNS: treatment strategies for the immunocompromised patient

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Improved outcome in central nervous system aspergillosis, using voriconazole treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Refractory candidal meningitis in an immunocompromised patient cured by caspofungin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candida endophthalmitis: focus on current and future antifungal treatment options

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Fungal infections in drug users

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candida glabrata endophthalmitis treated successfully with caspofungin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Management of endogenous fungal endophthalmitis with voriconazole and caspofungin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers: report of three cases and literature review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Infective endocarditis in adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Fungal endocarditis, 1995-2000.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A systematic review of population-based studies of infective endocarditis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A meta-analysis of medical versus surgical therapy for Candida endocarditis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candida albicans tricuspid and pulmonic valve endocarditis: challenge of relapsing risk and role of combined medical treatment and surgery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candida infective endocarditis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Fungal endocarditis: evidence in the world literature, 1965-1995.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Incidence and risk of developing fungal prosthetic valve endocarditis after nosocomial candidemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Cure of Candida glabrata native tricuspid valve endocarditis by continuous infusion of conventional amphotericin B in a patient with nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient--case report and review of literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

The Role of Candida sp Isolated From Bronchoscopic Samples in Nonneutropenic Patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Practices in non-neutropenic ICU patients with Candida-positive airway specimens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Increase in aspergillosis and severe mycotic infection in patients with leukemia and MDS: comparison of the data from the Annual of the Pathological Autopsy Cases in Japan in 1989, 1993 and 1997.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Pulmonary disease caused by Candida species

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Concomitant Candida epiglottitis and disseminated Varicella zoster virus infection associated with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Clinical significance of Candida isolated from peritoneum in surgical patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candida peritonitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Neonatal peritoneal candidiasis successfully treated with anidulafungin add-on therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Fungal arthritis and osteomyelitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Delivery of antifungal agents using bioactive and nonbioactive bone cements

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candida albicans osteomyelitis of the spine: progressive clinical and radiological features and surgical management in three cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Successfully treated Candida krusei infection of the lumbar spine with combined caspofungin/posaconazole therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Successful treatment of Candida tropicalis arthritis, osteomyelitis and costochondritis with caspofungin and fluconazole in a recipient of bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Hepatosplenic candidiasis: successful treatment with fluconazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Adjuvant corticosteroid therapy for chronic disseminated candidiasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Etiology of esophageal disease in human immunodeficiency virus-infected patients who fail antifungal therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Response and relapse rates of candidal esophagitis in HIV-infected patients treated with caspofungin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Vulvovaginal candidosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Antifungal drugs in pregnancy: a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Vaginal discharge--causes, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Fungal infections in primary immunodeficiencies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Human dectin-1 deficiency and mucocutaneous fungal infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A homozygous CARD9 mutation in a family with susceptibility to fungal infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

A case of chronic mucocutaneous candidasis cured with micafungin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Amphotericin B colloidal dispersion for treatment of candidemia in immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

The central nervous system and infection by Candida species

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Candida albicansEndophthalmitis in Brown Heroin Addicts: Response to Early Vitrectomy Preceded and Followed by Antifungal Therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02040.X

21 January 2018

Identifiers

10.1111/J.1439-0507.2011.02040.X

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37889382&oldid=2092818184"